- Communication
Patients with Chronic Lymphocytic Leukemia Have a Very High Risk of Ineffective Response to the BNT162b2 Vaccine
- Andrea Galitzia,
- Luca Barabino,
- Roberta Murru,
- Giovanni Caocci,
- Marianna Greco,
- Giancarlo Angioni,
- Olga Mulas,
- Sara Oppi,
- Stefania Massidda and
- Alessandro Costa
- + 1 author
Patients with CLL have high rates of either severe disease or death from COVID-19 and a low response rate after COVID-19 vaccination has been reported. We conducted a single-center study with the main objective to evaluate the immunogenicity of the B...

